Journal
SCIENCE CHINA-CHEMISTRY
Volume 53, Issue 11, Pages 2241-2249Publisher
SCIENCE PRESS
DOI: 10.1007/s11426-010-4122-9
Keywords
nanotechnology; nanomaterials; nanocarrier; cancer therapy; drug delivery; passive target; active target
Categories
Funding
- Ministry of Science and Technology of China [2011CB933401, 2010CB934004]
- National Natural Science Foundation of China [31070854]
- Chinese Academy of Sciences [KJCX2-YW-M02]
Ask authors/readers for more resources
Recent development in nanotechnology has provided new tools for cancer therapy and diagnostics. Because of their small size, nanoscale devices readily interact with biomolecules both on the cell surface and inside the cell. Nanomaterials, such as fullerenes and their derivatives, are effective in terms of interactions with the immune system and have great potential as anticancer drugs. Comparatively, other nanomaterials are able to load active drugs to cancer cells by selectively using the unique tumor environment, such as their enhanced permeability, retention effect and the specific acidic microenvironment. Multifunctional and multiplexed nanoparticles, as the next generation of nanoparticles, are now being extensively investigated and are promising tools to achieve personalized and tailored cancer treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available